Post-COVID Thrombotic Risk Composite (D-dimer + Clinical) Calculator
Clinical risk factor assessment
Select each clinical factor and provide D-dimer information to calculate the IMPROVE-DD point total.
—Score
About IMPROVE-DD
IMPROVE-DD adds D-dimer elevation to clinical risk factors from the IMPROVE VTE model. The point weights displayed here are the factors and weights implemented in the supplied calculator.
Scoring criteria
| Factor | Points |
|---|---|
| Age > 60 years | 1 |
| Previous VTE (DVT/PE) | 3 |
| Known thrombophilia | 2 |
| Lower-limb paralysis or paresis | 2 |
| Active cancer | 2 |
| Immobilization ≥ 7 days | 1 |
| ICU/CCU stay | 1 |
| D-dimer ≥2× ULN | 2 |
Important interpretation limits
- In the original IMPROVE-DD validation, a score ≥2 identified heightened VTE risk in hospitalized medically ill patients receiving thromboprophylaxis; this is not a validated standalone post-discharge treatment threshold for COVID-19.
- MICHELLE trial eligibility used an IMPROVE VTE score ≥4, or a score of 2–3 with D-dimer >500 ng/mL; this is not identical to applying the IMPROVE-DD score bands above.
- Evaluate clinical probability and investigate suspected DVT/PE using an appropriate diagnostic pathway; this calculator does not diagnose or exclude VTE.
References
Gibson CM, et al.IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Prediction of VTE Risk. TH Open. 2017;1:e56–e65. DOI / article
Ramacciotti E, et al.Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE). Lancet. 2022;399:50–59. DOI / article
American Society of Hematology (ASH).Living guidelines on anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary. Blood Advances. 2025;9:1247–1260. DOI / guideline
Clinical disclaimer: For clinician education and decision support only. This calculator is not a substitute for individualized clinical assessment or current local protocols. Do not start, stop, or extend anticoagulation based on this score alone. Consider bleeding risk, contraindications, renal function, patient preferences, and the clinical indication.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.